Powell Andrew Kenneth William
CIK 0001304113
Director
Filings
8
Latest Jun 4, 2024
Issuers covered
3
Showing
8 of 8
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +0.8% | +0.8% | +1.6% | 0.0% |
| 90 days | 2 | 0% | -16.1% | -16.1% | -15.3% | -16.8% |
| 180 days | 2 | 0% | -5.6% | -5.6% | -3.2% | -8.0% |
| 365 days | 2 | 100% | +56.2% | +56.2% | +58.1% | +54.4% |
Issuers
Companies where Powell Andrew Kenneth William has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | 5 | Jun 4, 2024 |
| LFCR | Lifecore Biomedical, Inc. \de\ | 2 | Jun 7, 2022 |
| SPRY | Ars Pharmaceuticals, Inc. | 1 | Jun 13, 2022 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|